Table: Fuji Pharmaceutical -2017/18 parent results

Fuji Pharma

09/11/2018 07:30

Nov 9 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2018    Sep 30, 2017   Sep 30, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           35.43           32.99          34.22        17.52    
               (+7.4 pct)      (+3.1 pct)     (-3.4 pct)    (+5.1 pct) 
  Operating        4.06            4.14                                
               (-2.0 pct)      (+17.1 pct)                             
  Recurring        4.23            4.48           4.34         2.56    
               (-5.4 pct)      (+39.3 pct)    (+2.5 pct)   (+12.2 pct) 
  Net              3.23            3.24           3.34         1.88    
               (+0.0 pct)      (+50.7 pct)    (+3.4 pct)   (+10.6 pct) 
  EPS          108.02 yen      108.10 yen     111.66 yen    62.82 yen  
  Ann Div                       48.00 yen      29.00 yen               
  -Q2 Div       28.00 yen       23.00 yen      14.00 yen               
  -Q4 Div       14.00 yen       25.00 yen      15.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T